Differences in NF-κB sequences render clade B-targeting siRNAs less effective against clade C viruses [79], which is why S4-siRNA was developed to target the unique NF-κB binding sequences in HIV-1 subtype C, responsible for more than half of all global HIV-1 infections. This evidence concerns the gene NFKB1 and HIV-1 infection.